Sonoma Pharmaceuticals, Inc.
For the period ended Mar 31, 2026. Filed Jun 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 16, 2026
SNOA$1.13+1.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
At March 31, 2026, we have a corporate office in Boulder, Colorado and our manufacturing facility in Zapopan, Mexico. We currently lease the following material properties:
| Locations | Rent per month | Purpose |
|---|---|---|
| 1) 5445 Conestoga Court, Unit 150, Boulder, CO 80301 | USD 3,688 | Principal executive office |
| 2) Industria Vidriera 81, & 87 Zapopan Industrial Norte, Zapopan, Jalisco, 45135, Mexico | MXN 209,811 | Office, manufacturing |
| 3) Industria Maderera 106, 115 & 815 Zapopan Industrial Norte, Zapopan, Jalisco, 45135, Mexico | MXN 213,625 | Office, warehouse |
We believe that our properties will be adequate to meet our needs for at least the next 12 months.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.